N-(1,3-benzodioxol-5-ylmethyl)-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine-6-carboxamide
C21H14F3N5O3 — CID 134793285
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(1,3-benzodioxol-5-ylmethyl)-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine-6-carboxamide
N-(1,3-benzodioxol-5-ylmethyl)-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine-6-carboxamide (PubChem CID 134793285) has the molecular formula C21H14F3N5O3 and a molecular weight of 441.37 g/mol. Its IUPAC name is N-(1,3-benzodioxol-5-ylmethyl)-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine-6-carboxamide.
Molecular Properties
| Compound Name | N-(1,3-benzodioxol-5-ylmethyl)-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine-6-carboxamide |
|---|---|
| PubChem CID | 134793285 |
| Molecular Formula | C21H14F3N5O3 |
| Molecular Weight | 441.37 g/mol |
| Exact Mass | 441.10 |
| IUPAC Name | N-(1,3-benzodioxol-5-ylmethyl)-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine-6-carboxamide |
| SMILES | O=C(NCc1ccc2c(c1)OCO2)c1cc(-c2cccc(C(F)(F)F)c2)c2nncn2n1 |
| InChI | InChI=1S/C21H14F3N5O3/c22-21(23,24)14-3-1-2-13(7-14)15-8-16(28-29-10-26-27-19(15)29)20(30)25-9-12-4-5-17-18(6-12)32-11-31-17/h1-8,10H,9,11H2,(H,25,30) |
| InChIKey | OXMOVZVWJBGIIF-UHFFFAOYSA-N |
| XLogP | 3.47 |
| TPSA | 90.64 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 441.37 |
| LogP ≤ 5 | 3.47 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134793285 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.